Context: 

The Meet & Greet the EU series is part of EFA’s 2022 Capacity Building Programme. Following our 2021 Meet & Greet with the EMA on patients’ engagement, this session aims to further develop Member knowledge of the form and function of the European Medicines Agency (EMA), the new EU regulation expanding its mandate, and the entry into force of the Clinical Trials Regulation and what it all means for patients living with respiratory and allergic diseases. 

EFA Objective: 

INFORM: EFA builds patient evidence, momentum, and capacity for change in prevention, care and participation for people with allergy and airways diseases

Specific Objectives:

• Increase Member understanding of the EMA’s extended mandate for a greater role in crisis preparedness and management for medicinal products and medical devices, and what it means for patients
• Improve Member knowledge of the Clinical Trials Regulation (Regulation (EU) No 536/2014), its tools and functions as well as the implications for patients participating in clinical trials, including recruitment, consent and access to information

Target audience

Staff, volunteers and members of the Board of EFA members. Open also to patients non-attached to an EFA member, provided they belong to patient groups active in the field of respiratory disease. 

Expected attendance

10 allergy and respiratory patients, patient advocates and/or carers. EFA staff and speakers will also be in attendance.

Thank you for your interest in participating in the Meet & Greet the EU training. To register and reserve your spot, please complete the registration form below. Please note that the in-person registration is reserved for EFA Members and other patients representatives of the community. 

Discover the Event Agenda